HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype
Journal for ImmunoTherapy of Cancer · 2024
DOI: 10.1136/jitc-2023-008146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Fan Luo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis an…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Tumor-Associated Macrophages, Immunotherapy, Cholesterol, HDL. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Guangzhou Key Research and Development Plan, Chinese National Natural Science Foundation, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background
The sustained effectiveness of anti-programmed cell death protein-1/programmed death-ligand 1 treatment is limited to a subgroup of patients with advanced nasopharyngeal carcinoma (NPC), and the specific biomarker determining the response to immunotherapy in NPC remains uncertain.
Methods
We assessed the associations between pre-immunotherapy and post-immunotherapy serum lipoproteins and survival in a training cohort (N=160) and corroborated these findings in a validation cohort (N=100). Animal studies were performed to explore the underlying mechanisms. Additionally, the relationship between high-density lipoprotein-cholesterol (HDL-C) levels and M1/M2-like macrophages, as well as activated CD8+T cells in tumor tissues from patients with NPC who received immunotherapy, was investigated.
Results
The lipoproteins cholesterol, HDL-C, low-density lipoprotein-cholesterol, triglycerides, apolipoprotein A-1 (ApoA1), and apolipoprotein B, were significantly altered after immunotherapy. Patients with higher baseline HDL-C or ApoA1, or those with increased HDL-C or ApoA1 after immunotherapy had longer progression-free survival, a finding verified in the validation cohort (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Unit, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, S…
- Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Ya…
- Department of Clinical Research, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun…
- Department of Radiotherapy, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.
- Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun…
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer,…
ORCID-Profile: Fan Luo, Qun Chen, Ting Zhou, Hongyun Zhao
Förderung
- Guangzhou Key Research and Development Plan
- Chinese National Natural Science Foundation
- China Postdoctoral Science Foundation
- National Postdoctoral Program for Innovative Talents
Zitieren
APA
Luo, F., Cao, J., Chen, Q., Liu, L., Yang, T., Bai, X., Ma, W., Lin, C., Zhou, T., Zhan, J., Huang, Y., Yang, Y., Zhao, H., & Zhang, L. (2024). HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-008146
Vancouver
Luo F, Cao J, Chen Q, Liu L, Yang T, Bai X, et al. HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2023-008146
BibTeX
@article{Luo2024,
author = {Luo, Fan and Cao, Jiaxin and Chen, Qun and Liu, Lusha and Yang, Ting and Bai, Xue and Ma, Wenjuan and Lin, Chaozhuo and Zhou, Ting and Zhan, Jianhua and Huang, Yan and Yang, Yunpeng and Zhao, Hongyun and Zhang, Li},
title = {HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
doi = {10.1136/jitc-2023-008146}
}
EUVIMED